The purpose of this document is to highlight cases in which Advocacy, Communication and Social Mobilization (ACSM) interventions have contributed to a positive outcome of tuberculosis (TB) control activities directed to a range of audiences and settings. It is intended for on-the-ground stakeholders who are interested in successfully integrating ACSM strategies and activities into TB control programming, as well as for decision-makers who can provide greater political and financial support for ACSM activities at the national, sub-national and international level.
Favorite
International Agencies
Managers and Supervisors
Outreach Workers
2010
This document addresses a broad range of ethical issues arising in TB programmes, ranging from informed consent and isolation to health-care workers' rights and obligations, and clinical and epidemiological studies.
Favorite
International Agencies
2010
The case highlighted in this issue came from a state health department nurse who lived in the small town located on a large Great Plains Indian reservation where this case unfolded. It involved an extended family spanning 4 generations, all of whom lived in the same 3-bedroom house.
Favorite
Health Educators/Communicators
Managers and Supervisors
Medical and Nursing School Students
Outreach Workers
Social Service Providers
2010
The challenges of TB-HIV co-Infection are highlighted in this issue. Psychosocial aspects of HIV diagnosis and self-awareness are also discussed.
Favorite
Health Educators/Communicators
Managers and Supervisors
Medical and Nursing School Students
Outreach Workers
Social Service Providers
2010
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.
Favorite
International Agencies
Policy Makers
2010
The guidelines show how people with HIV can be protected from tuberculosis with regular, low-cost preventive medication. The guidelines present a set of recommendations that will help reduce TB disease in people living with HIV, their families and communities through a combination of screening for TB and provision of IPT.
Favorite
International Agencies
Policy Makers
2010
Drs. Jacques Grosset and Timothy Sterling will discuss the rationale for and potential new approaches to treatment of TB in HIV-infected individuals. Primary and secondary resistance of TB medications and the role of therapeutic drug monitoring for HIV-infected patients will be explored. The application of research to clinical practice will be highlighted.
Favorite
2010
The Checklist is designed to provide CHWs, supervisors, and program managers (from NTPs, NGOs, CBOs, and others) with very practical ways to properly implement TB IC and to minimize risk of transmission within community residential settings, including families and households.
Favorite
Infection Control and Occupational Health Workers
2010
This fact sheet provides basic information on the TB skin test.
Favorite
Persons With LTBI
2010
Luís Figo’s "I Am Stopping Tuberculosis" campaign consists of materials including posters, computer wallpaper, and postcards delivering key messages on tuberculosis.
Favorite
Children/Adolescents
Health Educators/Communicators
2010
This interactive resource aims to offer practical tools to nurses and anyone else involved in caring for patients, families and communities affected by TB including drug-resistant TB.
Favorite
2010
This hospital discharge approval request form is required in New York City as New York City Health Code mandates health care providers to obtain approval
from the New York City Department of Health & Mental Hygiene (DOHMH) before discharging infectious TB patients from the hospital.
Favorite
2010
The New York City Health Code requires all health care providers to submit a written TB Treatment Plan to the New York City Department of Health & Mental
Hygiene (DOHMH) within one month of starting treatment for newly diagnosed TB patients.
Favorite
2010
The STOP TB Partnership's theme for World TB Day 2010 is "On the Move Against Tuberculosis: Innovate to accelerate action." This year's campaign will focus on individuals around the world who have found new ways to stop TB and can serve as an inspiration to others. The idea is to recognize people who have introduced a variety of innovations in a variety of settings...
Favorite
2010
This book provides guidelines to national TB program managers, policy makers, nongovernmental organizations, and donor agencies on effective management of TB. The guidelines focus on the technical and managerial aspects of treatment.
Favorite
Policy Makers
2010
This tool estimates the risk of active tuberculosis for an individual with a tuberculin skin test reaction of 5+mm, based on his/her clinical profile. It is intended for adults tested with standard tuberculin (5 TU PPDS, or 2 TU RT-23).
Favorite
2010
Popularly known as “The Orange Guide”, the 6th edition of this small book provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens.
Favorite
International Agencies
Managers and Supervisors
2010
The Truth About TB website is part of a new campaign to get people talking and thinking about TB. The campaign is being developed by TB Alert, the UK's national Tuberculosis charity. The website includes stories by people who have been affected by TB, questions and answers about TB, and a variety of resources.
Favorite
Policy Makers
2010
This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB)...
Favorite
International Agencies
Policy Makers
2010
This report assesses how and why the IOM's tuberculosis elimination plan has not been fully implemented and provides updated action plans to move forward on its recommendations to accelerate progress toward tuberculosis elimination in the United States.
Favorite
Policy Makers
2010
